Tracker · 132 filings · 0 today

Regulatory tracker

Daily aggregated filings from FDA, DEA, SEC, CMS, and the Federal Register, filtered for mental health relevance.

Latest regulatory coverage

REGULATION

Almost every branded psychiatric drug in America now sits inside a pricing deal nobody voted on

The White House added nine more drugmakers to its most-favored-nation pricing program, bringing the total to 26 companies covering an estimated 89 percent of the branded drug market. None of the new nine build their business around psychiatric drugs. That's beside the point: the company that makes esketamine signed on months ago, and the whole arrangement is voluntary, unenforced by law, and largely undisclosed to Congress.

More regulatory coverage (6) →
REGULATION

Puerto Rico opens a research-policy review on psychedelics and ibogaine. It has not approved any clinical use.

Executive Order 2026-037 creates a scientific advisory committee to study whether Puerto Rico should build a pilot clinical research program for emerging therapies, including psilocybin, MDMA, and ibogaine, with veterans named as a priority population. The order explicitly does not authorize any clinical use of these compounds, a distinction worth stating plainly before the headline runs ahead of it.

REGULATION

Medicare proposes cutting physician pay for 2027. Behavioral health is one of the few specialties partly shielded from why.

CMS's newly proposed physician fee schedule cuts both Medicare conversion factors for 2027, a real, system-wide reimbursement headwind. But the same rule proposes extending Medicare's telehealth mental health flexibility through the end of 2027, and last year's most contested pay cut specifically exempted the time-based codes psychiatry and psychotherapy mostly bill under. The rule is a mixed signal, not a uniform one, and the mix matters more than the headline number.

REGULATION

DEA moves to schedule tianeptine, the other 'gas station' compound quietly building a mortality record

A federal Schedule I proposal would close the retail loophole that has let tianeptine, an atypical antidepressant abroad and an opioid-like supplement in unregulated US retail, spread through the same gas-station-and-smoke-shop channel as kratom's concentrated derivatives. It is the third distinct DEA scheduling action against this retail category in two weeks.

Regulatory tracker

October 9, 2026
DEA
Schedules of Controlled Substances; Removal of Exemption Status for Inactive Butalbital Products
scheduling

The Drug Enforcement Administration (DEA) is revoking the exempted status for certain nonnarcotic prescription products that are currently on DEA's Table of Exempted Prescription Products, but whose National Drug Codes (NDC) are inactive because they are no longer available and/o

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of O-Desmethyltramadol in Schedule I; Correction
scheduling

On August 12, 2026, the Drug Enforcement Administration (DEA) published a temporary order placing O-desmethyltramadol (other names: O-DSMT; desmetramadol; 3-[(1R,2R)-2-[(dimethylamino)methyl]-1- hydroxycyclohexyl]phenol), including its salts, isomers, and salts of isomers wheneve

View on Federal Register
CT
Efficacy of Islamic Integrated Forgiveness Therapy (IIFT) in Marital Relationship
research

Marital Transgression, Marital Relationship, Forgiveness, Depression, Anxiety, Stress, Ruminations — Islamic Integrated Forgiveness Therapy (IIFT), Enright's Forgiveness Therapy (EFT)

View on ClinicalTrials.gov
CT
Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma
research

Depression, Anxiety, Trauma Patients — D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol

View on ClinicalTrials.gov
CT
PREWELL Digital Well-being Promotion Intervention With the BitHabit App
research

General Mental Health and Well-Being, Mental Disorders, Common Mental Disorders (CMD) — Digital wellbeing promoting intervention with the BitHabit app

View on ClinicalTrials.gov
CT
Peer Support for Family Caregivers of Older Adults Living With Dementia
research

Caregiver Burden, Caregiver Burnout, Caregiver Anxiety, Alzheimer Disease Dementia — Peer Support, Usual Care

View on ClinicalTrials.gov
CT
Therapeutic Benefits of Pareidolia in Acute Traumatic Brain Injury Patients
research

Traumatic Brain Injuries — Therapeutic Benefits of Pareidolia, Active Comparator #1

View on ClinicalTrials.gov
CT
Transcendental Meditation Intervention to Reduce Burnout and Enhance Resilience Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents
research

Anxiety, Depression - Major Depressive Disorder, Burnout, Insomnia, Resilience, Feasibility, Acceptability — Transcendental Meditation

View on ClinicalTrials.gov
CT
Health Anxiety From the Pandemic Initiative
research

Health Anxiety — THIS WAY UP iCBT, 90SecondHealth Anxiety

View on ClinicalTrials.gov
CT
Virtual Reality-Guided Imagery in Hemodialysis Patients ( VRGI-HD )
research

End-Stage Kidney Disease (ESKD) — virtual reality-guided imagery (VRGI)

View on ClinicalTrials.gov
CT
Post-traumatic Estradiol Administration and Care Evaluation (PEACE)
research

Chronic Musculoskeletal Pain, Sexual Assault, Posttraumatic Stress Disorder (PTSD) — 17β-estradiol, Placebo

View on ClinicalTrials.gov
CT
Self-administered Neurostimulation Intervention for Firefighter Traumatic Stress to Reduce Alcohol Use: Pilot Study
research

Posttraumatic Stress Symptoms, Heavy Alcoholic Consumption, Alcohol Use Disorder (AUD) — Transcutaneous auricular neurostimulation (tAN), Active Sham

View on ClinicalTrials.gov
CT
Feasibility Trial of a Parent Peer-Co-Led Caregiver Group for Pediatric Early Onset Schizophrenia Spectrum Disorders
research

Schizophrenia; Psychosis — Group Therapy, Treatment as Usual (TAU)

View on ClinicalTrials.gov
October 8, 2026
CT
Lakota Family Acceptance Project Pilot RCT
research

LGBTQ, Racial Disparities, Family Relationships, Minority Stress, Depression, Anxiety, Drug Use, Teen Dating Violence, Sexual Risk Reduction — Adapted Lakota Family Acceptance Program

View on ClinicalTrials.gov
CT
Transdiagnostic Sleep Intervention to Improve Mental Health in Adolescents
research

Sleep Disturbance, Sleep Problems, Substance Use (Drugs, Alcohol), Anxiety, Depression — Transdiagnostic Intervention for Sleep and Circadian Dysfunction, Healthy habits psychoeducation

View on ClinicalTrials.gov
CT
Hawai'i Postpartum Onset Depression Study
research

Postpartum Depression (PPD), Postpartum Anxiety

View on ClinicalTrials.gov
CT
Determination of Optimal Exercise Duration Using Intradialytic Exercises on Dialysis Adequacy, Fatigue, Depression, VO2 Max, Muscle Strength, Physical Functioning, and Quality of Life in Patients Undergoing Hemodialysis
research

Hemodialysis — Combined Aerobic and Resistance Exercise, Combined Aerobic and Resistance Exercise, Combined Aerobic and Resistance Exercise

View on ClinicalTrials.gov
CT
Psychological Prehabilitation for Complex Gastrointestinal Surgery
research

Post-traumatic Stress Symptoms, Anxiety, Depression Disorder, Gastrointestinal Disease — PREPARE-GI

View on ClinicalTrials.gov
CT
Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty Versus Applied Relaxation
research

Mental Disorders, Mood Disorders, Anxiety Disorders, Generalized Anxiety Disorder — Group Transdiagnostic Cognitive Behavioural Therapy for Intolerance of Uncertainty (CBT-IU), Group Transdiagnostic Applied Relaxation (AR)

View on ClinicalTrials.gov
CT
Implementation of Virtual Reality in Nuclear Medicine
research

Virtual Reality — ReviMed group, Control Group (A):

View on ClinicalTrials.gov
CT
Group Skills Training (DBT vs CBT) for Alexithymia in Young Adult Women
research

Alexithymia, Anxiety, Interpersonal Problems, Emotion Regulation — DBT-based Group Skills Training (DBT-GST), CBT-based Group Skills Training (CBT-GST)

View on ClinicalTrials.gov
CT
Adapting and Implementing a Chronic Disease Self-Management Program for Primary Care Patients With Opioid Use Disorder and Serious Mental Illness.
research

Implementation Science, Chronic Disease Self-management, Mental Illness, Addiction, Primary Care Patients With Chronic Conditions — The Chronic Disease Self-Management Program (CDSMP), Treatment as Usual plus self-management information

View on ClinicalTrials.gov
CT
Smartphone Addiction and Upper Extremity Sensorimotor Performance
research
CT
Addiction Psychoeducation for Canadian Muslims
research

Knowledge Gaps, Attitudes, Stigma of Mental Illness, Help-seeking Intention — Culturally sensitive addiction psychoeducation program, Secular

View on ClinicalTrials.gov
CT
Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)
research

Schizophrenia and Other Psychotic Disorders, Healthy Adult — Methylene Blue

View on ClinicalTrials.gov
October 7, 2026
CT
Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
research

Premenstrual Dysphoric Disorder (PMDD)

View on ClinicalTrials.gov
CT
Gamified Virtual Reality Exercise for Suicidal Ideation in Older Adults
research

Suicidal Ideation, Mental Health, Depression, Geriatric Psychiatry, Aging — Gamified VR-Based Exercise Program, Conventional Exercise Program

View on ClinicalTrials.gov
CT
High-Intensity Interval Training and Mental Health in Psychiatric Inpatients: A Pilot Study
research

Anxiety, Depression, Mental Health, Psychiatric Inpatients — High-Intensity Interval Training (1 × 4)

View on ClinicalTrials.gov
CT
An Interrupted Time-Series Pilot Trial of LGBTQ-Affirming Cognitive Processing Therapy for Interpersonal and Developmental Trauma
research

Post-Traumatic Stress Disorder, Chronic, Depressed Mood, Depressive and Anxiety Disorders, Anxiety, Depression - Major Depressive Disorder — Cognitive Processing Therapy

View on ClinicalTrials.gov
CT
EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
research

Major Depressive Disorder (MDD), Treatment Resistant Depression, Major Depression — MagVenture TMS Therapy System with Localite Navigation System and actiCHamp EEG

View on ClinicalTrials.gov
CT
Cervical Cancer Awareness Education to Aid Confidence and Screening upTake (ACT): A Pilot Randomised Control Trial
research

Anxiety, Cervical Cancer Screening, Health Education, Wellbeing — cervical cancer Awareness education to aid Confidence and screening upTake (ACT), Control group

View on ClinicalTrials.gov
CT
Virtual Reality-Supported Relaxation Before Objective Structured Clinical Examination
research

Virtual Reality — Experimental

View on ClinicalTrials.gov
CT
Virtual Reality Storytelling Versus Storybook Reading for Dental Anxiety in Children
research

Dental Anxiety, Dental Anxiety in Children, Preoperative Anxiety — Virtual Reality Storytelling, Traditional Storybook Reading

View on ClinicalTrials.gov
CT
Assessing Trauma-related Links Between Affective and Metabolic Systems
research

Posttraumatic Stress Disorder, Metabolic Syndrome, Insulin Resistance — prazosin

View on ClinicalTrials.gov
CT
RECONNECT - Treatments for Complex PTSD
research

Complex Post-Traumatic Stress Disorder (CPTSD) — Prolonged Exposure, EMDR, ESTAIR

View on ClinicalTrials.gov
CT
Digital Cognitive Behavioral Therapy for Gambling Disorder: A Pilot Randomized Controlled Trial
research

Gambling Disorder, Gambling — Digital Cognitive Behavioral Therapy for Gambling Disorder, Digital Family Intervention for Gambling-Related Harms, Face-to-Face Cognitive Behavioral Therapy for Gambling Disorder

View on ClinicalTrials.gov
October 6, 2026
FDA
Design and Safety Considerations for Clinical Trials Involving Ibogaine Drug Products; Request for Information
psychedelics

The Food and Drug Administration (FDA or the Agency) is describing the approaches it is considering for the design of early- phase clinical trials of ibogaine drug products and is opening a public docket to receive comments. The Department of Health and Human Services (HHS) is fu

View on Federal Register
CT
Islamic Spiritual Care Versus Psychological Support in Radiotherapy
research

Cancer — IHSAN Model-based Islamic Spiritual Care, CBT-based Psychological Support

View on ClinicalTrials.gov
CT
Midday Bright Light Therapy for Bipolar Depression
research

Bipolar Disorder (BPD) — Bright Light Therapy, Placebo Light Therapy

View on ClinicalTrials.gov
CT
Anorexia Nervosa, Evaluation and MOdification of Attention
research

Anorexia Nervosa, Attentional Bias, Psychophysiology, Food, Interoception, Anxiety — Attentional Bias Modification Training

View on ClinicalTrials.gov
CT
Emotion Diary Application
research

Emotion Journal, Pediatric Intensive Care, Emotion Regulation, Emotional Awareness — Emotion Diary Administration

View on ClinicalTrials.gov
CT
Neurofeedback Therapy Added to Cognitive Behavioural Therapy-Based Psychoeducation for Test Anxiety Among Undergraduate Students: A Randomised Controlled Trial
research

Test Anxiety, Test Anxiety Scale, Exam Anxiety — Neurofeedback Therapy, Cognitive Behavioural Therapy-based Psychoeducation

View on ClinicalTrials.gov
CT
Humor-Based Video Intervention on Preoperative Anxiety Veya Humor Video and Recovery in Cholecystectomy
research

Preoperative Anxiety, Laparoscopic Cholecystectomy — Humor-Based Video Intervention, Routine Preoperative Care and Education

View on ClinicalTrials.gov
CT
Virtual Reality During Coronary Angiography
research

Coronary Angiography (CAG) — Virtual Reality Application

View on ClinicalTrials.gov
October 5, 2026
CT
Enhancing Wellbeing in Community Dwelling Seniors Through Structured Arts-Based Programmes in the Active Ageing Centres: A Mixed Method Study.
research

Wellbeing, Social Isolation in Older Adults, Social Prescribing, Anxiety Depression, Quality of Life (QOL) — Music / Visual Arts

View on ClinicalTrials.gov
CT
Brief Psychoanalytic Therapy Versus Cognitive Behavioral Therapy for Major Depressive Disorder
research

Major Depressive Disorder (MDD — Brief Psychoanalytic Therapy, Cognitive Behavioral Therapy

View on ClinicalTrials.gov
CT
Effects of School-Based Ignatian Examen Meditation on Well-Being, Gratitude, Hope, and Spirituality in Hong Kong Catholic Primary School Students
research

Psychological Well-being, Gratitude, Hope, Spirituality, Stress, Anxiety, Depression — Examen Meditation

View on ClinicalTrials.gov
CT
Evaluating the Therapeutic Potential of Focal Electrically Administered Seizure Therapy (FEAST) in the Treatment of Depression: A Multicenter Randomized Clinical Trial
research

Major Depressive Episode (MDE), Unipolar Disorder, Bipolar 1 Disorder — Stimulation by the Sigma ECT/FEAST device, Stimulation by Sigmastim ECT 200J device administered in right unilateral (RUL), Stimulation by Sigmastim ECT 200J device administered in bilateral (BT)

View on ClinicalTrials.gov
CT
Seasonality, Chronotype, Impulsivity, and Suicidality in Mood Disorder Patients
research

Bipolar Disorder in Remission, Major Depression in Remission

View on ClinicalTrials.gov
CT
Intuitive Eating Intervention After Bariatric Surgery
research

Weight Regain After Bariatric Surgery and Food Addiction, Eating Behavior, Body Image — Intuitive Eating Intervention, Standard Nutritional Counseling

View on ClinicalTrials.gov
CT
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
research

Well Being, Drug Addiction, Tobacco Use, Alcohol Abuse, Life Skills, Violence, Bullying, Health Literacy — life skills primary prevention

View on ClinicalTrials.gov
CT
Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
research

Schizophrenia, Bipolar Affective Disorder — Quetiapine (drug), quetiapine + aripiprazole, quetiapine + haloperidol

View on ClinicalTrials.gov
October 2, 2026
CT
Digital Tai Chi Intervention on Physical Fitness, Anxiety, Depression and Stress Among College Students
research

Health College Students — Virtual Reality-Assisted Tai Chi Training

View on ClinicalTrials.gov
CT
Effect of Psychosocial Intervention on Body Image, Self Esteem, Burn Anxiety and Depression Among Patients With Burn
research

Burn Patients, Psychosocial, Body Image, Self Esteem, Anxiety, Depression — Psychosocial Intervention

View on ClinicalTrials.gov
CT
Is Craving a Central Criterion for Diagnosing a Behavioral Addiction?
research

Addictive Behaviors, Internet Addiction Disorder, Gambling, Technology Addiction, Food Addiction, Compulsive Sexual Behavior, Screen Use — Questionnaires, Telephone interview

View on ClinicalTrials.gov
CT
Neuronavigated rTMS for Treatment-Resistant Auditory Hallucinations
research

Schizophrenia, Auditory Verbal Hallucinations — Neuronavigated repetitive transcranial magnetic stimulation (rTMS), Sham repetitive transcranial magnetic stimulation (rTMS)

View on ClinicalTrials.gov
CT
Understanding Lifespan Trajectories of Social Cognition, Brain Microstructure and Iron Dysregulation in Schizophrenia
research

Healthy Control Subjects, Schizophrenia Diagnosis

View on ClinicalTrials.gov
CT
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
research

SCHIZOPHRENIA 1 (Disorder), Schizoaffective Disorder, Healthy Adult Participants — Motion Perception Task, Sine Wave Speech Task, Volatility Task

View on ClinicalTrials.gov
CT
Cryoneurolysis Versus Bipolar Radiofrequency Ablation of Genicular Nerves for Pain Relief in Symptomatic Knee Osteoarthritis
research

Cryoneurolysis, Bipolar Radiofrequency Ablation, Genicular Nerves, Pain Relief, Symptomatic, Knee Osteoarthritis — Ultrasound-guided cryoneurolysis, Bipolar radiofrequency ablation

View on ClinicalTrials.gov
October 1, 2026
CMS
Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update; Correction

This document corrects technical errors in the final action that appeared in the July 31, 2026 Federal Register titled "Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System--Rate Update".

View on Federal Register
DEA
Extension of Reexportation Period.
scheduling

This proposed rule would amend the regulations of the Drug Enforcement Administration (DEA) to extend the time allowed for reexports of controlled substances outside of the European Economic Area from 180 days from the date of original release from U.S. Customs and Border Protect

View on Federal Register
CT
Validation of an Algorithm for Predicting Awakenings Associated With Trauma-related Nightmares, Based on the Analysis of Physiological Patterns in Military and Former Military Patients Suffering From Post-traumatic Stress Disorder
research

PTSD - Post Traumatic Stress Disorder, Trauma-related Nightmares — CAUD-PIN (CAUchemar Detection on INdividualized Parameters) - AI-based predictive algorithm forTrauma-related nightmare awakenings

View on ClinicalTrials.gov
CT
Anger, Social Cognition and Post-traumatic Stress Disorder in Former French Military Personnel
research

Post Traumatic Stress Disorder

View on ClinicalTrials.gov
CT
HBOT Effects on First Responders' Cognition and Well-Being
research

Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms — Hyperbaric Oxygen Therapy (HBOT)

View on ClinicalTrials.gov
CT
Sleep Architecture, Cognitive Function, and Quality of Life During Early Recovery From Substance Use Disorder
research

Substance-Related Disorders, Substance Use Disorder, Sleep Wake Disorders, Cognitive Dysfunction

View on ClinicalTrials.gov
CT
Brave Heart Intervention and Mental Health Outcomes Among Young People in Sierra Leone
research

Substance-related Disorders, Mental Health Literacy, Adolescent Health, Substance Use Disorder (SUD) — Brave Heart Intervention

View on ClinicalTrials.gov
CT
Effects of Psilocybin on Craving in Nicotine Dependence
psychedelics · research

Nicotine Dependence — Psilocybin (drug)

View on ClinicalTrials.gov
CT
iTBS Versus Standard 10 Hz rTMS for Treatment-Resistant Depression (TRD)
research

Major Depression — iTBS, rTMS

View on ClinicalTrials.gov
CT
Motivational Intervention for Patients With Schizophrenia
research

Schizo-affective Disorder, Non Organic Psychosis, Schizophenia Disorder — Positive Emotion Program for Schizophrenia (PEPS), a psychotherapeutic intervention,

View on ClinicalTrials.gov
CT
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
research

Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 — Abiraterone Acetate, Biospecimen Collection, Bone Scan

View on ClinicalTrials.gov
September 30, 2026
CT
Assessment of the Preventive Effect of Defusing on Traumatic Kindling
research

Acute Stress Disorder, Post Traumatic Stress Disorder PTSD — Defusing, Psychological First Aid (PFA)

View on ClinicalTrials.gov
CT
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study
research

Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms, PTSD — Hyperbaric Oxygen Therapy (HBOT)

View on ClinicalTrials.gov
CT
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder During Pregnancy
research

Methamphetamine Use Disorder, Pregnancy — 4- Week Dual-Target Transcranial Magnetic Stimulation (TMS), Accelerated Dual-Target Transcranial Magnetic Stimulation (aTMS), Treatment as Usual (TAU)

View on ClinicalTrials.gov
CT
Brain Imaging of DSP-2342
research

SCHIZOPHRENIA 1 (Disorder) — DSP-2342

View on ClinicalTrials.gov
CT
The Parasite and Infestation Study
research

Parasite and Infestation Physician-Patient Diagnostic Incongruency — No intervention - observational study

View on ClinicalTrials.gov
September 29, 2026
CT
Youth Overdose & Use Reduction in Rural Systems
research

Substance Abuse, Opioid Abuse (Disorder), Overdose Prevention, Substance Use Disorder (SUD), Adolescent Substance Use, Rural Health — Navigator - Flexible Care Management

View on ClinicalTrials.gov
CT
Brain Connectivity and Inflammatory Markers During Short-Term Psychotherapy for Treatment-Resistant Depression
research

Depressive Disorder, Treatment-Resistant — Short-Term Dynamic Psychotherapy, Mindfulness-Based Cognitive Therapy

View on ClinicalTrials.gov
September 28, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Irvine Labs, Inc.
scheduling

Irvine Labs, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cargill, Incorporated
scheduling

Cargill, Incorporated has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Benuvia Operations, LLC
scheduling

Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
CT
Parenting-STAIR Modular for Military Fathers and OCONUS Families
research

Depressive Symptoms, Emotional Depression, Depression, Parent Child Relationship, Parent-Child Relationship, Parent-Child Relations, Stress Disorder, Post Traumatic, PTSD, Parenting, Child Behavior, Emotional Regulation, Emotion Regulation — Parenting-STAIR Modular (PSTAIR-M), Tr

View on ClinicalTrials.gov
CT
Mechanism of BCI-Based Dual-Target Neurofeedback Training in Improving Cognitive Control Deficits in Internet Gaming Disorder
research

Internet Gaming Disorder — "Activate Neural Circuits + Promote Social Rewards" Dual-target Neurofeedback Training, "Activate Only the Neural Circuits" Neurofeedback Training, Sham Feedback

View on ClinicalTrials.gov
CT
TORCH - Transdiagnostic Observation of Risk Factors, Craving and Health Behaviours in Psychiatric Patients
research

Psychiatric Disorders — person-centred interventions

View on ClinicalTrials.gov
CT
Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder
research

Alcohol Use Disorder — Thiamine

View on ClinicalTrials.gov
CT
The ICEC Cluster Trial: Integrated Community Engagement Collaborative for Youth Substance Use Prevention in Rural America
research

Substance Use (Drugs, Alcohol), Tobacco Use, Adolescent Substance Use — Integrated Community Engagement Collaborative, School-Based Data Collection and Reporting without Network Coordinator Support

View on ClinicalTrials.gov
CT
Prevalence and Association of Dysfunctional Breathing With Nicotine Dependence and Physical Activity Among Young Smokers
research

Dysfunctional Breathing, Physical Activity, Nicotine Dependence — Observational evaluation.

View on ClinicalTrials.gov
CT
Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
research

Treatment Resistant Depression (TRD) — Dehydroepiandrosterone (DHEA), Placebo

View on ClinicalTrials.gov
CT
Targeted Alternating Current and Cognitive Training Intervention for Cognitive Control in Bipolar Disorders
research

Bipolar Disorder, Bipolar and Related Disorders, Veterans, Suicide, Suicidal Ideation, Mental Disorders — Soterix 1x1 tES mini-CT

View on ClinicalTrials.gov
September 25, 2026
FDA
Jeffrey Thies: Final Debarment Order
scheduling

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Jeffrey Thies for a period of 10 years from importing or offering for import any drug into the United States. FDA bases this order on a fin

View on Federal Register
CT
Deep Brain Reorienting for Posttraumatic Stress Disorder
research

Posttraumatic Stress Disorder (PTSD), Posttraumatic Stress Symptom — Deep Brain Reorienting, Treatment as Usual (TAU)

View on ClinicalTrials.gov
CT
Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation
research

Opioid Use Disorder, Major Depressive Disorder (MDD) — Transcranial Magnetic Stimulation (TMS), Sham Transcranial Magnetic Stimulation (TMS)

View on ClinicalTrials.gov
CT
Examining the Relationship Between Ongoing Alcohol Use, Suicidal Thoughts and Behaviors and Related Constructs, and Behavioral Economic Decision-Making.
research

Alcohol Use Disorder (AUD), Suicidal Ideation — CBT4CBT

View on ClinicalTrials.gov
CT
A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.
research

Schizophenia Disorder — WAS123, Aripiprazole (Fixed dose)

View on ClinicalTrials.gov
CT
Psychotherapy for Self-Disorders in Schizophrenia Spectrum Disorder
research

Schizophrenia Spectrum Disorders (SSD) — SELF-7, F-ACT

View on ClinicalTrials.gov
September 24, 2026
DEA
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
scheduling

Cayman Chemical Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
scheduling

Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Fisher Clinical Services, Inc. (I)
scheduling

Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

View on Federal Register
DEA
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
scheduling

Cambridge Isotope Laboratories, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

View on Federal Register
CT
Creative Art Teletherapy for Veterans With PTSD
research

Post-Traumatic Stress Disorder F03.950.750.500 D013313 — Art-therapy Remote Treatment for Veterans Experiencing Trauma

View on ClinicalTrials.gov
CT
Measurement-Based Care to Support Buprenorphine-Naloxone Treatment in Outpatient Addiction Clinics
research

Opioid Use Disorder — Bup-MBC

View on ClinicalTrials.gov
CT
Oral and Topical Phytocannabinoids for Psoriasis
cannabis · research

Psoriasis Vulgaris — Oral Cannabis Extract, Topical cannabis cream

View on ClinicalTrials.gov
CT
Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder
cannabis · research

ADHD, Cannabis Use Disorder — Delayed-release, extended-release methylphenidate, Placebo

View on ClinicalTrials.gov
September 23, 2026
FDA
Sanjay Kumar: Final Debarment Order
scheduling

The Food and Drug Administration (FDA or the Agency) is issuing an order under the Federal Food, Drug, and Cosmetic Act (FD&C Act) debarring Sanjay Kumar for a period of 5 years from importing or offering for import any drug into the United States. FDA bases this order on a findi

View on Federal Register
DEA
Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I
scheduling

The Drug Enforcement Administration proposes placing five tryptamine hallucinogens, 4-hydroxy-N,N-diisopropyltryptamine (other names: 4-OH-DiPT; 3-(2-(diisopropylamino)ethyl)-1H-indol-4- ol), 5-methoxy-alpha-methyltryptamine (other names: 5-MeO-AMT; 1-(5- methoxy-1H-indol-3-yl)pr

View on Federal Register
CT
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
research

Post Traumatic Stress Disorder — TSND-201, Placebo

View on ClinicalTrials.gov
CT
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
research

Tobacco Use Disorder/Cigarette Smoking, HIV — nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster

View on ClinicalTrials.gov
CT
The Interactive Media and Gender-related Stressors and Strengths Study
research

Eating Disorders, Substance Use — digital web based toolkit

View on ClinicalTrials.gov
CT
Psychological Resilience and Quality of Life Among Caregivers of Patients With Schizophrenia
research

Schizophrenia, Caregiver Burden, Quality of Life

View on ClinicalTrials.gov
CT
A Closed Unit Incorporating Soteria Elements Versus a Conventional Closed Psychiatric Ward
research

Psychotic Disorders — Inpatient Care in a Closed Unit Incorporating Soteria Elements, Conventional Closed Psychiatric Inpatient Care

View on ClinicalTrials.gov
September 22, 2026
CT
Home-Based Randomized Trial of Spaced Transcranial Direct Current Stimulation for Treatment-Resistant Depression
research

Treatment Resistant Depression (TRD), Major Depressive Disorder (MDD) — Spaced Transcranial Direct Current Stimulation (tDCS), Sham Spaced tDCS

View on ClinicalTrials.gov
CT
State Representation in Early Psychosis 2
research

Early Psychosis, Psychosis, Schizophrenia, Bipolar Disorder With Psychosis, Schizoaffective Disorder

View on ClinicalTrials.gov
CT
Body Weight Changes After Switching to Lurasidone for Antipsychotic-induced Weight Gain in Bipolar Disorder
research

Bipolar Disorder (BD) — Lurasidone

View on ClinicalTrials.gov
CT
Cognition and Affective Research in China
research

Neurodegenerative Disease, Dementia, Alzheimer's Disease, Parkinson's Disease, Mood Disorders, Depression, Anxiety Disorder, Bipolar Disorder, Behavior Disorders

View on ClinicalTrials.gov
September 21, 2026
DEA
Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
scheduling

With the issuance of this final rule, the Drug Enforcement Administration places the substance diphenidine (1-(1,2- diphenylethyl)piperidine), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in sc

View on Federal Register
CT
Transforming Trauma Care
research

Post-Traumatic Stress Disorder (PTSD), Depression, Substance Use Disorder, Traumatic Injury — Trauma Resilience and Recovery Program Portal 2.0 (TRRP 2.0)

View on ClinicalTrials.gov
CT
Physiopathology of Behavioral Addictions and Biomarkers
research

Food Addiction, Sexual Addiction — blood sampling

View on ClinicalTrials.gov
CT
Attachment and Substance Use Disorder: An Interventional Study in an Addictology Day Hospital
research

Addiction Disorders — attachment-focused therapeutic program, psychoeducation-based intervention (standard care)

View on ClinicalTrials.gov
September 18, 2026
CT
Assessment of Childbirth-Related Post-Traumatic Stress Disorder
research

Childbirth-related Post-traumatic Stress Disorder — City Birth Trauma Scale and Questionnaire on the assessment of healthcare utilization

View on ClinicalTrials.gov
September 17, 2026
CT
Imaging Mitochondrial Complex-I in Alcohol Use Disorder
research

Alcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched — [F-18]BCPP-EF, [F-18]FDG

View on ClinicalTrials.gov
CT
Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder
research

Methamphetamine Use Disorder — Tirzepatide, Placebo (saline)

View on ClinicalTrials.gov
CT
Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism
research

Alcohol Use Disorder (AUD), Alcohol Related Liver Disease — Endurance Exercise

View on ClinicalTrials.gov
CT
Ketamine Treatment for Treatment-Resistant Depression - the Role of Framing
psychedelics · pharma · research

Treatment Resistant Depression (TRD) — Psychedelic framing, Biomedical framing

View on ClinicalTrials.gov
September 16, 2026
CT
The Effects of Trauma-informed Care Organization on Birth Professionals and Women's Experiences of Trauma.
research

Post-Traumatic Stress Disorder, Psychological Trauma — trauma-informed care training

View on ClinicalTrials.gov
September 15, 2026
CT
A Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial Intelligence
research

Substance-related Disorders, Behavior, Addictive, Artificial Intelligence (AI) — Questionnaire assessment

View on ClinicalTrials.gov
CT
4-STEP Training Program for Social Media Addiction, Cognitive Fatigue, Psychological Distress, Academic Burnout and Procrastination Among Students
research

Social Media Addiction — 4-STEP-TPS

View on ClinicalTrials.gov
CT
Breaking the Cycle of Social Media Addiction: Efficacy of a 4-STEP Training Program in Reducing Cognitive Fatigue, Psychological Distress, Academic Procrastination, and Burnout Among Adolescents
research

Social Media Addiction — 4-STEP-TPS

View on ClinicalTrials.gov
CT
Building a Computational Model of Auditory Hallucinations
research

Schizophrenia / Schizoaffective Disorder, Schizophrenia and Disorders With Psychotic Feature, Psychosis, SCHIZOPHRENIA 1 (Disorder), Schizophreni-form Disorder

View on ClinicalTrials.gov
September 14, 2026
CT
CHW-Enhanced Trauma Recovery
research

Traumatic Injury, Posttraumatic Stress Disorder, Depression, Social Determinants of Health — CHW support

View on ClinicalTrials.gov
CT
Screening and Monitoring of Mental Health in Educational Settings: Programme for Detection, Psychoeducation and Self-help
research

Anxiety, Depression Disorder, Bullying, Addiction, Suicide, Self Harm, Psychosis, Eating Disorders — program for the detection, referral, and psychoeducation in adolescents

View on ClinicalTrials.gov
CT
tACS for Self-Other Boundary in Schizophrenia
research

Schizophrenia / Schizoaffective Disorder — Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (tACS)

View on ClinicalTrials.gov
CT
Effects of Nitraria Retusa Infusion on Clozapine-induced Metabolic Side Effects
research

Treatment Resistant Schizophrenia, Obesity & Overweight, Abdominal Obesity — The Nitraria retusa arm

View on ClinicalTrials.gov